CIK 0001468748 · Non-accelerated filer<br>Smaller reporting company
Kodiak Sciences Inc.
Sign in to watch- Ticker
- KOD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 270476525
- Phone
- 650-281-0850
- Business address
- 1250 PAGE MILL RD, PALO ALTO, CA, 94304
- Former names
- Oligasis, LLC
- Open-market buys, last 90 days
- $181,327,230
- in 4 filings
- Open-market sales, last 90 days
- $2,700,322
- in 1 filing, $2.7M under 10b5-1 plans
Net +$178,626,907. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 80 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-05 | BAKER BROS. ADVISORS LP Director | Purchase | +4,703 | $98.51 | $463K | 1,683,172 |
| 2026-11-05 | BAKER BROS. ADVISORS LP Director | Purchase | +81,729 | $98.51 | $8.1M | 20,424,859 |
| 2026-11-04 | BAKER BROS. ADVISORS LP Director | Purchase | +8,742 | $98.51 | $861K | 1,678,469 |
| 2026-11-04 | BAKER BROS. ADVISORS LP Director | Purchase | +151,916 | $98.51 | $15.0M | 20,343,130 |
| 2026-10-23 | Yang Taiyin Director | Option exercise | +20,000 | $2.35 | $47K | 20,000 |
| 2026-10-23 | Yang Taiyin Director | Option exercise · Stock Option (Right to Buy) | −20,000 | 20,000 | ||
| 2026-10-21 | BORGESON JOHN A. Chief Financial Officer | Option exercise 10b5-1 | +30,000 | $2.49 | $75K | 241,930 |
| 2026-10-21 | BORGESON JOHN A. Chief Financial Officer | Sale 10b5-1 | −8,514 | $87.67 | $746K | 233,416 |
| 2026-10-21 | BORGESON JOHN A. Chief Financial Officer | Sale 10b5-1 | −1,677 | $89.20 | $150K | 231,739 |
| 2026-10-21 | BORGESON JOHN A. Chief Financial Officer | Sale 10b5-1 | −7,623 | $89.74 | $684K | 224,116 |
| 2026-10-21 | BORGESON JOHN A. Chief Financial Officer | Sale 10b5-1 | −5,101 | $90.98 | $464K | 219,015 |
| 2026-10-21 | BORGESON JOHN A. Chief Financial Officer | Sale 10b5-1 | −2,985 | $91.76 | $274K | 216,030 |
| 2026-10-21 | BORGESON JOHN A. Chief Financial Officer | Sale 10b5-1 | −2,000 | $92.66 | $185K | 214,030 |
| 2026-10-21 | BORGESON JOHN A. Chief Financial Officer | Sale 10b5-1 | −2,000 | $93.71 | $187K | 212,030 |
| 2026-10-21 | BORGESON JOHN A. Chief Financial Officer | Sale 10b5-1 | −100 | $94.91 | $9K | 211,930 |
| 2026-10-21 | BORGESON JOHN A. Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −30,000 | 304,500 | ||
| 2026-09-29 | BAKER BROS. ADVISORS LP Director | Purchase | +619 | $84.24 | $52K | 1,668,448 |
| 2026-09-29 | BAKER BROS. ADVISORS LP Director | Purchase | +10,381 | $84.24 | $875K | 20,169,767 |
| 2026-09-29 | BAKER BROS. ADVISORS LP Director | Purchase | +1,195 | $85.40 | $102K | 1,669,643 |
| 2026-09-29 | BAKER BROS. ADVISORS LP Director | Purchase | +20,031 | $85.40 | $1.7M | 20,189,798 |
Page 1 of 20 · 388 trades